Suzhou Zelgen Biopharmaceuticals Co., Ltd.
SSE:688266.SS
114.92 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 2,153.679 | 2,109.641 | 797.047 | 1,136.632 | 1,149.734 | 66.92 | 128.932 | 9.885 | 17.025 |
| Short Term Investments
| 40.501 | 137.019 | 248.934 | 65.256 | 449.85 | 6 | 82.6 | 53 | 54 |
| Cash and Short Term Investments
| 2,194.18 | 2,246.66 | 1,045.981 | 1,201.887 | 1,599.584 | 72.92 | 128.932 | 9.885 | 17.025 |
| Net Receivables
| 153.009 | 101.14 | 88.985 | 62.371 | 2.62 | 0 | 0 | 0 | 0 |
| Inventory
| 182.861 | 110.852 | 98.978 | 51.911 | 23.138 | 6.425 | 2.553 | 0.48 | 0.166 |
| Other Current Assets
| 45.849 | 61.684 | 57.81 | 89.787 | 44.226 | 22.479 | 15.589 | 8.271 | 9.733 |
| Total Current Assets
| 2,575.899 | 2,520.336 | 1,291.755 | 1,405.956 | 1,669.568 | 101.824 | 229.675 | 71.636 | 80.924 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 363.428 | 271.205 | 247.089 | 188.911 | 91.025 | 56.669 | 56.983 | 46.815 | 35.46 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 50.011 | 69.27 | 91.03 | 116.291 | 129.514 | 135.807 | 156.427 | 12.839 | 13.148 |
| Goodwill and Intangible Assets
| 50.011 | 69.27 | 91.03 | 116.291 | 129.514 | 135.807 | 156.427 | 12.839 | 13.148 |
| Long Term Investments
| 0 | 5.988 | -238.934 | -55.256 | -439.85 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 238.934 | 78.282 | 454.201 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 15.277 | 20.408 | 38.437 | 11.777 | 65.824 | 25.968 | 11.797 | 16.341 | 7.67 |
| Total Non-Current Assets
| 428.715 | 366.871 | 376.556 | 340.005 | 300.714 | 218.444 | 225.207 | 75.994 | 56.278 |
| Total Assets
| 3,004.614 | 2,887.207 | 1,668.311 | 1,745.962 | 1,970.282 | 320.268 | 454.882 | 147.63 | 137.202 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 197.103 | 137.735 | 151.721 | 118.191 | 64.957 | 54.033 | 63.514 | 56.5 | 9.098 |
| Short Term Debt
| 951.862 | 795.165 | 390.793 | 131.809 | 17.67 | 60 | 0 | 0 | 0 |
| Tax Payables
| 33.446 | 20.638 | 29.016 | 25.1 | 24.659 | 17.979 | 0.944 | 0.33 | 0.079 |
| Deferred Revenue
| 0 | 0 | 0.279 | 87.265 | 0 | 0 | 0.045 | 0.956 | 0 |
| Other Current Liabilities
| 191.035 | 181.644 | 157.376 | 105.435 | 36.04 | 18.157 | 13.099 | 11.589 | 2.848 |
| Total Current Liabilities
| 1,373.446 | 1,135.181 | 729.186 | 380.893 | 140.877 | 150.168 | 77.557 | 69.376 | 12.025 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 71.212 | 29.456 | 93.277 | 48.176 | 34.352 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 9.202 | 11.546 | 45.04 | 48.046 | 83.658 | 66.222 | 61.94 | 5.23 | 15.74 |
| Deferred Tax Liabilities Non-Current
| 5.701 | 9.583 | 13.322 | 15.765 | 19.805 | 25.301 | 29.22 | 0 | 0 |
| Other Non-Current Liabilities
| 292.453 | 56.604 | 0 | 0 | 0 | 4.827 | 4.525 | 0 | 0 |
| Total Non-Current Liabilities
| 378.568 | 107.189 | 151.639 | 111.987 | 137.815 | 96.35 | 95.685 | 5.23 | 15.74 |
| Total Liabilities
| 1,752.014 | 1,242.37 | 880.825 | 492.88 | 278.692 | 246.518 | 173.242 | 74.606 | 27.765 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 264.708 | 264.708 | 240 | 240 | 240 | 180 | 40.421 | 34.284 | 32.654 |
| Retained Earnings
| -2,116.742 | -1,978.912 | -1,700.329 | -1,242.557 | -791.558 | -472.329 | -796.734 | -356.645 | -210.176 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 68.06 | 118.335 | 77.785 | 48.188 | 31.58 | 982.621 | 395.385 | 286.96 |
| Other Total Stockholders Equity
| 3,105.892 | 3,278.996 | 2,222.289 | 2,121.095 | 2,121.095 | 294.983 | 983.395 | 395.385 | 286.96 |
| Total Shareholders Equity
| 1,253.858 | 1,632.853 | 759.118 | 1,196.323 | 1,617.725 | 3.426 | 226.309 | 73.025 | 109.438 |
| Total Equity
| 1,252.601 | 1,644.837 | 787.486 | 1,253.082 | 1,691.59 | 73.75 | 281.64 | 73.025 | 109.438 |
| Total Liabilities & Shareholders Equity
| 3,004.614 | 2,887.207 | 1,668.311 | 1,745.962 | 1,970.282 | 320.268 | 454.882 | 147.63 | 137.202 |